Brexit panic is good news for bargain hunters

Professional investor William Meadon picks three of his favourite UK stocks.

A professional investor tells us where he'd put his money. This week: William Meadon of the JP Morgan Claverhouse Investment Trust picks three favourites.

There is a great deal of uncertainty surrounding the British economy and stockmarket. But despite all the doom and gloom, the economy is in better shape than many realise. Indeed, in stark contrast to the horror stories and negative headlines, what we're seeing on the ground, at the company level, are a number of bright spots. It's easy to miss these opportunities if you don't tune out the Brexit-related noise.

JPMorgan Claverhouse aims to provide both capital and income growth for its shareholders by investing in a portfolio of 60 to 80 quoted British equities: reasonably valued quality companies with improving prospects. The fund has just announced its 46th consecutive annual dividend increase, the longest of any UK-only investment trust quoted on the London Stock Exchange.

The housing gloom has gone too far

What's more, the Help-to-Buy programme is making house purchases more accessible and, if the scheme finishes as planned in 2023, there should be an increasing number of people taking advantage of it in the coming years. We particularly like Barratt Developments (LSE:BDEV) thanks to its strategy of focusing on areas outside London, where there is less concentrated Brexit risk and, consequently, lower house-price volatility. Barratt's management are experienced, astute operators and although the 8% dividend yield on the shares includes some special payments, even in the absence of these the shares looks attractive.

New managers will boost Glaxo

GlaxoSmithKline (LSE:GSK)

However, a change in management should gradually improve the reputation of the company. In the meantime, investors are being paid generously to wait through the quarterly payment of a dividend currently worth more than 5% of the share price. Furthermore, the recent joint venture with Pfizer's consumer health business highlights the strategic choices available to the company and the management's ability to exploit them.

A top record in infrastructure

John Laing Group (LSE: JLG)

Recommended

Brexit begins: what do the UK and the EU want from a trade deal?
Brexit

Brexit begins: what do the UK and the EU want from a trade deal?

With Brexit now done, the trade talks can begin. But who wants what from a UK/EU trade deal, and how likely are they to get it?
3 Feb 2020
Share tips of the week
Share tips

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Jan 2020
Share tips: eight stocks that should deliver robust returns
Share tips

Share tips: eight stocks that should deliver robust returns

Ryan Ermey of US publication Kiplinger’s Personal Finance chooses his favourite stocks for the next decade, which should be able to grow for years.
28 Dec 2019
Share tips of the week
Share tips

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 Dec 2019

Most Popular

The Bank of England should create a "Bitpound" digital currency and take the world by storm
Bitcoin

The Bank of England should create a "Bitpound" digital currency and take the world by storm

The Bank of England could win the race to create a respectable digital currency if it moves quickly, says Matthew Lynn.
18 Oct 2020
Don’t miss this bus: take a bet on National Express
Trading

Don’t miss this bus: take a bet on National Express

Bus operator National Express is cheap, robust and ideally placed to ride the recovery. Matthew Partridge explains how traders can play it.
19 Oct 2020
Three stocks that can cope with Covid-19
Share tips

Three stocks that can cope with Covid-19

Professional investor Zehrid Osmani of the Martin Currie Global Portfolio Trust, picks three stocks that he thinks should be able to weather the coron…
12 Oct 2020